Ratings by JMP Securities (Silvan Tuerkcan)

Date CompanySymbol Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
6/28/2021 Intellia Therapeutics NTLA Maintain Market Outperform
(N/A)
 
 
  Details
6/23/2021 Intellia Therapeutics NTLA Maintain Market Outperform
(N/A)
 
 
  Details
6/8/2021 Generation Bio GBIO New Coverage Market Outperform
(N/A)
26.88
(25.68)
-4.46% Details
6/8/2021 Taysha Gene Therapies TSHA New Coverage Market Outperform
(N/A)
22.32
(18.50)
-17.11% Details
5/6/2021 Turning Point Therapeutics Inc. TPTX Maintain Market Outperform
(Market Outperform)
 
 
  Details
3/29/2021 Relay Therapeutics RLAY Maintain Market Outperform
(Market Outperform)
 
 
  Details
3/4/2021 Intellia Therapeutics NTLA New Coverage Market Outperform
(N/A)
61.97
(148.36)
139.41% Details
3/4/2021 LogicBio Therapeutics LOGC New Coverage Market Outperform
(N/A)
8.32
(4.43)
-46.75% Details
3/4/2021 CRISPR Therapeutics CRSP New Coverage Market Outperform
(N/A)
129.77
(116.47)
-10.25% Details
1/12/2021 Turning Point Therapeutics Inc. TPTX Maintain Market Outperform
(N/A)
 
 
  Details
12/8/2020 Turning Point Therapeutics Inc. TPTX New Coverage Market Outperform
(N/A)
107.34
(78.89)
-26.5% Details
12/8/2020 Relay Therapeutics RLAY New Coverage Market Outperform
(N/A)
52.00
(36.22)
-30.35% Details
12/8/2020 Mirati Therapeutics MRTX New Coverage Market Outperform
(N/A)
233.26
(177.47)
-23.92% Details